A Pilot Phase IIB, Randomized, Multi-Center Trial of Argatroban in Combination with Recombinant Tissue Plasminogen Activator for Acute Stroke (ARTSS-2)

Grant

Date/time Interval

  • March 1, 2014 - September 1, 2015
  • Total Award Amount

  • 31794.00
  • Direct Costs

  • 21702.00
  • Sponsor Award Id

  • Contributor

  • Hays Shapshak, Angela   Principal Investigator  
  • Nabors M.D., Louis   Investigator